Spots Global Cancer Trial Database for metastatic soft tissue sarcoma

Every month we try and update this database with for metastatic soft tissue sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma	NCT02451943	Soft Tissue Sar...	Olaratumab Doxorubicin Placebo	18 Years -	Eli Lilly and Company
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma	NCT05711615	Metastatic Leio... Metastatic Sarc... Metastatic Soft... Unresectable Le... Unresectable Sa... Unresectable So...	Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Pegylated Lipos... Peposertib	18 Years -	National Cancer Institute (NCI)
Phase II Study of Regorafenib as Maintenance Therapy	NCT03793361	Metastatic Soft...	Regorafenib Placebo	18 Years -	Centre Oscar Lambret
Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas	NCT03660930	Advanced Soft T... Locally Advance... Metastatic Soft...	Sirolimus Album... Pazopanib hydro...	18 Years -	University of Washington
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma	NCT02451943	Soft Tissue Sar...	Olaratumab Doxorubicin Placebo	18 Years -	Eli Lilly and Company
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors	NCT05075993	Metastatic Esop... Gastric Cancer Metastatic Head... Metastatic Hepa... Metastatic HPV ... Metastatic Ovar... Metastatic Soft... Metastatic Uvea...	LVGN3616 + LVGN... LVGN3616 + LVGN... LVGN3616 + LVGN... LVGN3616 + LVGN...	18 Years -	M.D. Anderson Cancer Center
Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma	NCT03397186	Myxoid Liposarc... Round Cell Lipo... Stage III Soft ... Stage IV Soft T... Metastatic Soft... Unresectable So...	Biopsy Laboratory Biom... Trabectedin	18 Years -	Fred Hutchinson Cancer Center
Phase II Study of Regorafenib as Maintenance Therapy	NCT03793361	Metastatic Soft...	Regorafenib Placebo	18 Years -	Centre Oscar Lambret
Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas	NCT03670069	Metastatic Leio... Metastatic Syno... Metastatic Undi... Advanced Myxoid... Advanced Soft T... Metastatic Myxo... Metastatic Roun... Metastatic Soft... Refractory Leio... Refractory Myxo... Refractory Roun... Refractory Soft... Refractory Syno... Refractory Undi... Advanced Leiomy... Advanced Synovi... Advanced Undiff... Metastatic Chon...	Itacitinib Laboratory Biom...	18 Years -	Fred Hutchinson Cancer Center
A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma	NCT01440088	Soft Tissue Sar...	TH-302 in Combi... Doxorubicin	15 Years -	Threshold Pharmaceuticals
Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma	NCT04200443	Metastatic Leio... Metastatic Soft... Stage III Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri... Unresectable Le... Unresectable So...	Cabozantinib Quality-of-Life... Questionnaire A... Temozolomide	18 Years -	City of Hope Medical Center
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery	NCT03009201	Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un...	Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib	12 Years -	OHSU Knight Cancer Institute
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases	NCT03965234	Metastatic Bone... Metastatic Mali... Metastatic Soft... Metastatic Unre... Resectable Sarc... Colorectal Canc...	Cisplatin Isolated Chemot... Metastasectomy	18 Years -	Roswell Park Cancer Institute
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery	NCT03009201	Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un...	Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib	12 Years -	OHSU Knight Cancer Institute
Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma	NCT01514188	Metastatic Soft... Locally Advance... Unresectable So...	INNO-206 Doxorubicin	15 Years - 80 Years	ImmunityBio, Inc.
Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas	NCT00134641	Sarcoma, Soft T...	gemcitabine vinorelbine	18 Years -	Dana-Farber Cancer Institute
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery	NCT02500797	Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Bone... Metastatic Lipo... Metastatic Soft... Metastatic Undi... Metastatic Unre... Pleomorphic Lip... Stage III Bone ... Stage III Soft ... Stage IV Bone S... Stage IV Soft T... Stage IVA Bone ... Stage IVB Bone ... Unresectable Bo... Unresectable De... Unresectable Li... Unresectable Ma... Unresectable So...	Ipilimumab Laboratory Biom... Nivolumab Quality-of-Life...	18 Years -	National Cancer Institute (NCI)
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery	NCT03009201	Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un...	Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib	12 Years -	OHSU Knight Cancer Institute

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: